Proton Radiotherapy for Recurrent Tumors

Launched by ABRAMSON CANCER CENTER AT PENN MEDICINE · May 18, 2010

Keywords

ClinConnect Summary

Patients will be stratified by treatment site (Head and Neck, Thorax, Abdomen, Pelvis, Extremities) and by treatment volume (low volume, high volume) for a total of 10 strata. This study will be done in two phases. In the first phase, feasibility will be established using the primary objectives set below. The second phase will begin no earlier than 90 days after the last patient in the initial phase has completed treatment in each strata and once feasibility has been verified. The secondary objectives will serve as the objectives for the second phase of the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with histologically confirmed, non-CNS solid malignancies who have been previously radiated and have a tumor recurrence in or near prior radiation fields. Re-biopsy of the recurrence is not required and left to the discretion of the treating physician, although every effort should be made to confirm recurrence.
• • Patients must have a Karnofsky Performance Status of 60. Life expectancy of 3 months .
• • Age greater or equal to 18.
• • Patients must be able to provide informed consent.
• • Women of child bearing potential as long as she agrees to use a recognized method of birth control (e.g. oral contraceptive, IUD, condoms or other barrier methods, etc.)
• • Hysterectomy or menopause must be clinically documented.
• Exclusion Criteria:
• • Prior radiation treatment less than 3 months from planned start of re-irradiation of any part of the intended treatment volume.
• • Pregnant women, women planning to become pregnant and women that are nursing.
• • Actively being treated on any research study.